Valuation: CannaPharmaRX, Inc.

Market Cap	1.4M 1.25M 1.15M 1.05M 1.98M 133M 2.01M 13.88M 5.44M 69.39M 5.26M 5.15M 221M	P/E 2024	-0.51x	P/E 2025	-0.31x
Enterprise Value	22.05M 19.6M 18.17M 16.53M 31.19M 2.09B 31.69M 218M 85.62M 1.09B 82.75M 80.99M 3.48B	EV / Sales 2024	23,622,884x	EV / Sales 2025	17,663,843x
Free-Float	92.65%	Yield 2024 *	-	Yield 2025	-

* Estimated data More valuation ratios

Latest news: CannaPharmaRX, Inc.

Aug. 18	CannaPharmaRX, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
May. 20	CannaPharmaRX, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
Mar. 31	CannaPharmaRX, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
Mar. 30	CannaPharmaRX, Inc. Auditor Raises 'Going Concern' Doubt	CI
Jan. 13	Cannapharmarx, Inc. Announces Resignation of Director Rick Orman, Effective January 8, 2026	CI
Nov. 14	CannaPharmaRX, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
25-08-19	Cannapharmarx, Inc. Plans to Open Its Sixth Growing Room in September	CI
25-08-19	Cannapharmarx, Inc. Announces Series of Strategic Developments	CI
25-08-19	Cannapharmarx, Inc. Announces Revenue Guidance for Third Quarter 2025	CI
25-08-14	CannaPharmaRX, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
25-05-16	CannaPharmaRX, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
25-04-10	CannaPharmaRX, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
25-04-09	CannaPharmaRX, Inc. Auditor Raises 'Going Concern' Doubt	CI

More news

Press Releases: CannaPharmaRX, Inc.

25-05-06	CannapharmaRx Continues into New European Market with First Shipment Completed to Germany	AQ
23-06-23	CANNAPHARMARX, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	AQ
22-12-22	Canadian Cannabis; Down but Far from Out - Growth for 2023 and Beyond	NE
22-12-21	CannaPharmaRx Receives Cultivation License from Health Canada and Projects 2023 Revenue Over $30 Million	AQ
22-11-21	CANNAPHARMARX, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ

More press releases

Managers and Directors: CannaPharmaRX, Inc.

Manager	Title	Age	Since
Constantine Nkafu CEO	Chief Executive Officer	50	2024-09-06
Oliver Foeste DFI	Director of Finance/CFO	50	2023-10-12

Director	Title	Age	Since
Dominick Colvin BRD	Director/Board Member	57	2018-03-31
Anthony Panek BRD	Director/Board Member	41	2023-08-24
Constantine Nkafu BRD	Director/Board Member	50	2025-03-30

More insiders

CannaPharmaRX Inc. is a Canada-based cannabis company focused on producing medical cannabis and craft products. The Company operates from its facility in Cremona, Alberta, Canada and is able to produce over 6,000 kilograms per year. The Company is focused on the acquisition, development, and operation of cannabis cultivation facilities in Canada. The Company produces and sells dried cannabis flower, which is packaged for sale as dried flower and trim shake. It sells dried flowers for medicinal purposes. The Company's products include unique genetics, craft products, medical cannabis, its brands and licenses. Craft cannabis, also known as craft marijuana, is cannabis that is produced on a small scale by artisanal or independent producers.

Employees

Sector

Healthcare Facilities & Services

More about the company

Quotes

Date	Price	Change	Volume
26-10-15	$0.002000	0.00%	1,800
26-10-14	$0.002000	0.00%	4,308
26-10-13	$0.002000	0.00%	16,761
26-10-12	$0.002000	0.00%	10,333
26-10-09	$0.002000	0.00%	3,100

Delayed Quote OTC Markets

More quotes

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

Market Closed - OTC Markets 10:22:44 2026-10-15 am EDT			5-day change	1st Jan Change
0.002000 ^USD	0.00%		0.00%	-61.54%

3 months	+11.11%
6 months	-48.72%
Current year	-61.54%

1 week	0		0
1 month	0		0
Current year	0		0.01
1 year	0		0.01
3 years	0		0.03
5 years	0		0.05
10 years	0		4

Date	Insider	Type	% Market Cap.	Importance
12/30/25	Amir David Tal	Other	0%	-
12/30/25	Amir David Tal	Other	0%	-
12/30/25	Amir David Tal	Other	0%	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CANNAPHARMARX, INC.	0.00%	0.00%	-58.33%	-77.78%	1.4M
CVS HEALTH CORPORATION	-0.24%	+7.20%	+11.92%	+28.26%	118B
HCA HEALTHCARE, INC.	-2.06%	+1.72%	+7.67%	+88.07%	99.34B
NATERA, INC.	-2.80%	-1.81%	+116.54%	+825.74%	56.71B
FRESENIUS SE & CO. KGAA	+2.78%	+6.42%	-5.38%	+78.37%	28.56B
QUEST DIAGNOSTICS INCORPORATED	-1.74%	+1.74%	+24.00%	+90.61%	25.94B
LABCORP HOLDINGS INC.	-2.19%	+1.86%	+11.19%	+56.66%	25.79B
TENET HEALTHCARE CORPORATION	-2.86%	+1.32%	+33.62%	+373.09%	21.52B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	-0.27%	-2.46%	-20.43%	-2.63%	20.76B
REDE D'OR SÃO LUIZ S.A.	-0.65%	-6.95%	+4.36%	+84.85%	18.25B
Average	-1.00%	+0.72%	+12.52%	+154.52%	41.5B
Weighted average by Cap.	-1.19%	+2.40%	+23.90%	+179.49%

CannaPharmaRX, Inc. Stock

Stocks

CPMD

US13765D1090

Healthcare Facilities & Services

Valuation: CannaPharmaRX, Inc.

Chart: CannaPharmaRX, Inc.

Latest news: CannaPharmaRX, Inc.

Press Releases: CannaPharmaRX, Inc.

Quotes and Performance

Price Extremes

Managers and Directors: CannaPharmaRX, Inc.

Latest insider transactions

Medical Farming

Financials

Company Profile

Quotes

	2024	2025
Net sales	0.82 0.73 0.68 0.61 1.16 77.84 1.18 8.12 3.18 40.62 3.08 3.01 129.49	1.36 1.21 1.12 1.02 1.93 129.28 1.96 13.49 5.29 67.46 5.11 5 215.06
Net income	-9.91M -8.81M -8.16M -7.43M -14.01M -940M -14.24M -98.1M -38.46M -491M -37.18M -36.38M -1.56B	-11.13M -9.89M -9.17M -8.34M -15.75M -1.06B -16M -110M -43.22M -551M -41.78M -40.89M -1.76B
Net Debt	14.06M 12.5M 11.58M 10.54M 19.89M 1.33B 20.2M 139M 54.59M 696M 52.76M 51.64M 2.22B	20.65M 18.35M 17.01M 15.48M 29.21M 1.96B 29.68M 204M 80.18M 1.02B 77.49M 75.84M 3.26B